Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Nanovaccines to combat drug resistance : the next-generation immunisation
Avtorji:ID Manju, K. (Avtor)
ID Raj, S. Niranjan (Avtor)
ID Chouhan, Raghuraj S., Institut "Jožef Stefan" (Avtor)
ID Baker, Syed (Avtor), et al.
Datoteke:URL URL - Izvorni URL, za dostop obiščite https://rdcu.be/dkc76
 
.pdf PDF - Predstavitvena datoteka, prenos (1,39 MB)
MD5: C736D6406DBF78DC555E95C76B36DF41
 
Jezik:Angleški jezik
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:Logo IJS - Institut Jožef Stefan
Povzetek:Background. The present review envisages the role of nanovaccines to combat the global challenges of antimicrobial resistance. Nanovaccines are a novel formulation comprised of nanomaterials coupled with an immunogenic component to elicit the immune response and provide protection against the desired infectious disease. The nanovaccines with unique physicochemical properties can be more efficient against targeting the desired tissues in the body, aids in prolong circulation to promote antigen-presenting cells to act upon the target antigens. Main content. The present review envisages the development of nanovaccines against antimicrobial-resistant pathogens. The use of nanovaccines can exhibit potent antigenicity with prolonged retention and controlled release to induce both cell- and antibody-mediated responses. Nanovaccines usage is still in the early stages and can be next-generation immunisation for prophylactic and therapeutic efficiency. The future development of nanovaccines against multi-drug-resistant pathogens can explore new avenues. Based on these facts, the present review is designed from the previously reported scientific studies and compiled with the fact that nanovaccines can revolutionise vaccine strategies. The articles were extracted from reputed databases like PubMed, Scopus, and ESCI. The size and conjugating chemistry of nanomaterials can be beneficial in developing novel multi-nanovaccine formulations that can target pools of antimicrobial resistance mechanisms. Conclusion. Overall, the nanovaccines can form one of the best effective modes of targeting multi-drug-resistant pathogens. The nanovaccines can stimulate the innate immune response and generate effective immune-therapeutic novel formulation against infectious pathogens. Based on these facts and considerations, the present article makes an alarming call to develop nanovaccines to counter multi-drug resistance.
Ključne besede:nanovaccines, antimicrobial drug resistance, nanomaterials, HIV, WHO
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Poslano v recenzijo:01.06.2023
Datum sprejetja članka:25.07.2023
Datum objave:31.07.2023
Založnik:Springer Nature
Leto izida:2023
Št. strani:str. 1-15
Številčenje:Vol. 9, article no. 64
Izvor:Egipt
PID:20.500.12556/DiRROS-24741 Novo okno
UDK:620.3
ISSN pri članku:2314-7253
DOI:10.1186/s43094-023-00515-y Novo okno
COBISS.SI-ID:162054403 Novo okno
Avtorske pravice:© The Author(s) 2023.
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 23. 8. 2023;
Datum objave v DiRROS:16.12.2025
Število ogledov:15
Število prenosov:13
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Future Journal of Pharmaceutical Sciences
Skrajšan naslov:future j. pharm. sci.
Založnik:Future University, Elsevier
ISSN:2314-7253
COBISS.SI-ID:529689881 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:31.07.2023
Vezano na:VoR

Sekundarni jezik

Jezik:Slovenski jezik
Naslov:Nanovaccines to combat drug resistance: the next-generation immunisation
Ključne besede:nanocepiva, odpornost na antimikrobna zdravila, protimikrobna odpornost, nanomateriali, HIV, SZO


Nazaj